Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, and RNA modifications and cancer.
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Data from Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma
Data from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
Data from Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma
Data from Alterations of the Tumor Suppressor Gene <i>ARLTS1</i> in Ovarian Cancer
Data from MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
In situ hybridization to detect DNA amplification in extracellular vesicles
MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer
Tumour predisposition and cancer syndromes as models to study gene–environment interactions
miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer
Exosomal miRNA signatures of pancreatic lesions
Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
Abrogation of esophageal carcinoma development in miR-31 knockout rats
Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia
Fhit–Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells
WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
Correction: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer
Knockout of both miR-15/16 loci induces acute myeloid leukemia
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia
Loss of miR-204 expression is a key event in melanoma
Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine
Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats
Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis
Levels of miR-126 and miR-218 are elevated in ductal carcinoma <i>in situ</i> (DCIS) and inhibit malignant potential of DCIS derived cells